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Purpose: To report a case of uveal effusion syndrome associated with hypotony and a case of uveal 
effusion syndrome in nanophthalmos. 
Methods: The first case was a 25-year-old man who presented with decreased visual acuity in the left eye 
and hypotony. Fundus examination revealed choroidal effusion and retinal detachment with a thickened 
eyeball. Partial thickness sclerotomy and sclerectomy were performed. The second case was a 13-year-old 
boy who had uveal effusion syndrome with a nanophthalmic eye.
Results: In the patient with hypotony, intraocular pressure was well maintained following partial thickness 
sclerotomy and sclerectomy, and choroidal effusion and retinal detachment were reduced. The visual acuity 
of the nanophthalmic patient was well maintained during a 3-year follow-up period without treatment. 
Conclusions: appropriate treatment modalities should be considered depending on the ophthalmic condition 
of the individual patient.  Korean Journal of Ophthalmology 20(2):124-127, 2006
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Uveal effusion was first described by Schepens and 
Brockhurst in 1963.
1 In 1975 Brockhurst
2,3 reported this 
disorder in association with nanophthalmos and scleral 
abnormality, and proposed that subretinal fluid accumulation 
is caused by congestion of the choroidal venous system due 
to compression of the vortex veins by thick sclera. Brock-
hurst subsequently described a new surgical procedure 
involving decompression of the vortex vein. In this paper we 
report two cases of uveal effusion. The first patient presented 
with severe hypotony and decreased visual acuity. He was 
diagnosed with uveal effusion and received subscleral 
sclerectomy and sclerotomy. The second patient had uveal 
effusion and nanophthalmos. He demonstrated decreased 
visual acuity initially, but did not experience any further 
change during a follow up period of three years. 
Case Report
1. Case 1
A 25-year-old male presented with blurred vision in his 
left eye that had persisted for 5 days. He also complained 
of eyeball pain. He had no relevant general medical or ocular 
history, and took no medication. His best corrected visual 
acuity (BCVA) in right eye was 1.0 and that of the left eye 
was finger count 50 cm. Intraocular pressure (IOP) was 12 
mmHg in the right eye and 2mmHg in the left eye. Slit lamp 
examination showed cells 3+ in the left anterior chamber, 
posterior synechiae and posterior capsular opacity in the left 
eye. Fundus examination (Fig. 1) demonstrated shallow 
retinal detachment and choroidal folding in the left eye. No 
retinal breaks were found. Ultrasound examination (Fig. 2) 
revealed thickened sclera and choroidal detachment in the left 
eye. Fluorescein angiogram and indocyanine green (ICG) 
showed diffuse hyperfluorescence in the choroid that 
appeared in the early phase (10 seconds) and had almost 
disappeared in the late phase.
Administration of high-dose oral steroid and NSAID was 
not effective, therefore, high-dose intravenous steroid was 
administered. Subsequent IOP was 1 mmHg in the left eye 
and slit lamp examination showed cells 3+ in the left anterior 
chamber. No improvement was noted in the fundus 
examination. To correct the IOP, 0.7 cc 100% SF6 gas was 
injected into the vitreous; however the postoperative IOP 
remained 1 mmHg. Surgical treatment was therefore per-
formed on the left eye under general anesthesia. 
Subscleral sclerectomy was performed at two sites in the 
temporoinferior and nasoinferior quadrants. A half thickness 
scleral flap measuring 4×4 mm was made 8 mm from the 
limbus. Under the scleral flap, the remaining thickness of the 
sclera was excised in pieces measuring 2×2 mm, thereby 
exposing the choroid. The scleral flap was loosely sutured 
and C3F8 gas was injected into the vitreous. At postoperative 
1 week, IOP in the left eye was 46 mmHg, and Diamox
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Fig. 2. B - s c a n  u l t r a s o u n d  i n  c a s e  1  s h o w e d  t h i c k e n e d  e y e b a l l  a n d  c h o r o i dal  detachment  in  the  left  eye.
Fig. 1. Preoperative  color  photograph  of  case  1  showing  shallow 
retinal  detachments  and  choroidal  folding  in  the  left  eye. 
Cosopt
®, Alphagan
® and Xalatan
® were administered. One 
week later the IOP in the left eye was 17 mmHg. At 
postoperative 2 months, fundus examination (Fig. 3) revealed 
an attached retina and near complete resolution of the 
choroidal detachment. Five months after surgery, IOP was 11 
mmHg and BCVA was 0.1 in the left eye. No surgery-related 
side effects were noted and cataract surgery was considered 
to improve visual acuity. 
2. Case 2
A 13-year-old boy was referred to our hospital due to 
decreased visual acuity in both eyes over 2 years. He had no 
Fig. 3. Color  photograph  of  case  1  at  postoperative  2  months 
showing  attached  retina  and  near  complete  resolution  of  choroidal 
detachment. 
relevant general medical or ocular history, and took no 
medication. One year previously, brain MRI had revealed no 
abnormalities and an electoretinogram (ERG) showed 
decreased electrical signals. At presentation, BCVA was 0.5 
for both eyes and both spherical equivalents were +7.00D 
(diopter). Slip lamp examination showed no specific features, 
while fundus examination revealed tortuous dilated retinal 
vessels, serous retinal detachment and subretinal fluid at 
periphery, and choroidal folding and epiretinal membrane in 
both eyes (Fig. 4). Axial lengths were 18.96 mm in the right 
eye and 18.99 mm in the left eye in A-scan. A B-scan 
ultrasonogram showed thickened choroid, retinal detachment 
and choroidal detachment (Fig. 5). During a 3-year follow up 
period, fundus examination showed no interval change and Korean  J  Ophthalmol  Vol.20,  No.2,  2006
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Fig. 5. B-scan  ultrasound  in  case  2  showing  thickened  eyeball,  peripheral  retinal  detachment  and  choroidal  detachment.
Fig. 4. Color  photograph  of  case  2  showing  serous  retinal  detachments  and  epiretinal  membrane.
BCVA was 0.7 in the right eye and 0.6 in the left eye. He 
is currently under observation without any medication. 
Discussion
Schepens and Brockhurst
1 first described uveal effusion, 
showing non-rhegmatogenous retinal detachment and subre-
tinal fluid shift in 17 cases. Brockhurst
2,3 later reported that 
this disorder is related to nanophthalmos and scleral 
abnormality, and proposed that subretinal fluid accumulation 
is caused by congestion of the choroidal venous system due 
to compression of the vortex veins by thick sclera. In 1983 
Gass
4 reported thick sclera and uveal effusion in non- 
nanophthalmic patients. He proposed a new hypothesis in 
which congenital choroidal abnormalities, such as thickened 
choroid and abnormal vortex veins, cause uveal effusion, and 
he introduced a surgical procedure involving scleral resection 
without decompression of the vortex vein. 
Trelstad et al.
5 found that in uveal effusion syndrome, the 
sclera showed histochemical abnormalities: The bundles of 
collagen fibers in the sclera had a markedly irregular arrange-
ment and varied in width, and abnormal deposition of 
glycosaminoglycan among the collagen bundles was noted.
6-8 
Uveal effusion syndrome may be divided into three groups 
according to its pathogenesis: 1) Uveal effusion caused by 
intraocular inflammation due to ocular trauma, intraocular 
surgery and scleritis; 2) Uveal effusion caused by hypotony 
and thickened sclera; 3) Idiopathic causes. Uyama et al.
7 
reported 17 cases of uveal effusion syndrome and divided 
them into 3 groups. Type 1 was a nanophthalmic eye with 
axial length less than 19 mm, a high grade of hypermetropia 
in refraction, and a rigid, thick sclera. Type 2 was a 
non-nanophthalmic eye with thick sclera but no high degree 
of hypermetropia. Type 3 was a non-nanophthalmic eye JH  Lee,  et  al.  UVEAL  EFFUSION
127
without scleral thickening and a normal eyeball size Type 3 
thus corresponded to idiopathic uveal effusion. They reported 
that types 1 and 2 showed similar clinical features and 
surgery was effective for both, while surgical treatment was 
not effective in type 3. They concluded that scleral abnor-
mality is the main cause of primary uveal effusion syndrome 
in types 1 and 2. It is known that idiopathic uveal effusion 
has a poorer prognosis than other types, and that surgery or 
systemic steroid therapy is not effective.
In 1986, Oum
9 reported subscleral sclerectomy in a case 
of uveal effusion syndrome in Korea. In 1996 Song et al.
10 
reported a case of nanophthalmos with choroidal effusion in 
which anterior sclerotomy for the drainage of the uveal 
effusion was effective. 
We report two cases of uveal effusion. The first patient, 
who presented with severe hypotony and decreased visual 
acuity, was diagnosed with uveal effusion and received 
subscleral sclerectomy and subscleral sclerotomy. The second 
case was a patient with uveal effusion and nanophthalmos 
who initially showed decreased visual acuity, but did not 
experience any change during the follow up period of three 
years with no treatment.
In conclusion, in the management of uveal effusion, 
appropriate treatment modalities should be considered on an 
individual basis depending on the patient’s ophthalmic 
condition.
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